510(k) K790713

ANTISERUM TO HUMAN HEMOPEXIN by Kent Laboratories, Inc. — Product Code CZX

K790713 is an FDA 510(k) premarket notification submitted by Kent Laboratories, Inc. for the device "ANTISERUM TO HUMAN HEMOPEXIN". The FDA issued a decision of Substantially Equivalent on Sep 4, 1979. The device falls under product code CZX (Hemopexin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5490. Kent Laboratories, Inc. has 39 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Sep 4, 1979
Date Received
Apr 12, 1979
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Hemopexin, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5490
Review Panel
IM
Submission Type
510(k) Exempt

Need the full FDA record for Kent Laboratories, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K790713. Report a data issue: hello@regdatalab.com.